Literature DB >> 1851800

CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration.

T H Rand1, W W Cruikshank, D M Center, P F Weller.   

Abstract

Lymphocyte chemoattractant factor (LCF) is a tetrameric glycoprotein of 56,000 relative molecular mass produced by activated T lymphocytes. LCF binds to CD4 and has previously been found to stimulate migration of CD4+ lymphocytes and monocytes. Because human eosinophils, like T cells and monocytes, express CD4, we examined functional responses of eosinophils to LCF. Recombinant LCF (rLCF) expressed in COS cells was purified on a CD4 affinity column. Migration of eosinophils was elicited by rLCF at low concentrations: the 50% effective dose (ED50) was 10(-12) to 10(-11) M, concentrations 100- to 1,000-fold lower than the ED50s for the recognized eosinophil chemoattractants C5a and platelet-activating factor. Two other ligands which bound to CD4, human immunodeficiency virus-1 envelope glycoprotein gp120 and monoclonal antibody OKT4, also stimulated eosinophil migration. Monovalent OKT4 Fab competitively inhibited eosinophil responses to rLCF. rLCF did not influence other functional responses of eosinophils tested, including degranulation, superoxide generation, leukotriene C4 production, in vitro survival, or surface expression of the adherence receptor CR3 (CD11b), human histocompatibility leukocyte antigen DR, or interleukin 2 receptor p55 (CD25). We conclude that CD4 on eosinophils is capable of transducing a migratory stimulus and serves as a receptor for a chemoattractant lymphokine LCF. T cell-derived LCF may contribute to recruitment of eosinophils and CD4+ mononuclear cells concomitantly at inflammatory reactions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1851800      PMCID: PMC2190841          DOI: 10.1084/jem.173.6.1521

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  18 in total

1.  Interaction between CD4 and class II MHC molecules mediates cell adhesion.

Authors:  C Doyle; J L Strominger
Journal:  Nature       Date:  1987 Nov 19-25       Impact factor: 49.962

2.  Lymphocyte activation by HIV-1 envelope glycoprotein.

Authors:  H Kornfeld; W W Cruikshank; S W Pyle; J S Berman; D M Center
Journal:  Nature       Date:  1988-09-29       Impact factor: 49.962

3.  Heterogeneity of leukotriene C4 production by eosinophils from asthmatic and from normal subjects.

Authors:  M K Hodges; P F Weller; N P Gerard; S J Ackerman; J M Drazen
Journal:  Am Rev Respir Dis       Date:  1988-10

Review 4.  The CD4 antigen: physiological ligand and HIV receptor.

Authors:  Q J Sattentau; R A Weiss
Journal:  Cell       Date:  1988-03-11       Impact factor: 41.582

5.  Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen.

Authors:  D Gay; P Maddon; R Sekaly; M A Talle; M Godfrey; E Long; G Goldstein; L Chess; R Axel; J Kappler
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

6.  Nedocromil sodium and cromolyn (sodium cromoglycate) selectively inhibit antibody-dependent granulocyte-mediated cytotoxicity.

Authors:  T H Rand; A F Lopez; J R Gamble; M A Vadas
Journal:  Int Arch Allergy Appl Immunol       Date:  1988

7.  Release of lysosomal enzyme beta-glucuronidase from isolated human eosinophils.

Authors:  T Marshall; P Shult; W W Busse
Journal:  J Allergy Clin Immunol       Date:  1988-10       Impact factor: 10.793

8.  Chemoattractant lymphokines specific for the helper/inducer T-lymphocyte subset.

Authors:  J S Berman; W W Cruikshank; D M Center; A C Theodore; D J Beer
Journal:  Cell Immunol       Date:  1985-10-01       Impact factor: 4.868

9.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.

Authors:  S H Zigmond; J G Hirsch
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

10.  Recombinant human interleukin 5 is a selective activator of human eosinophil function.

Authors:  A F Lopez; C J Sanderson; J R Gamble; H D Campbell; I G Young; M A Vadas
Journal:  J Exp Med       Date:  1988-01-01       Impact factor: 14.307

View more
  38 in total

1.  Increased levels of interleukin-16 in the airways of tobacco smokers: relationship with peripheral blood T lymphocytes.

Authors:  M Laan; I Qvarfordt; G C Riise; B A Andersson; S Larsson; A Lindén
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

Review 2.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

3.  Down regulation of CD4 expression following isolation and culture of human monocytes.

Authors:  G M Graziani-Bowering; L G Filion
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

Review 4.  Mechanisms of eosinophil cytokine release.

Authors:  Christianne Bandeira-Melo; Peter F Weller
Journal:  Mem Inst Oswaldo Cruz       Date:  2005-06-14       Impact factor: 2.743

Review 5.  Whipple's disease: a macrophage disease.

Authors:  Benoît Desnues; Melanie Ihrig; Didier Raoult; Jean-Louis Mege
Journal:  Clin Vaccine Immunol       Date:  2006-02

6.  Rapid temporal dynamics of transcription, protein synthesis, and secretion during macrophage activation.

Authors:  Katrin Eichelbaum; Jeroen Krijgsveld
Journal:  Mol Cell Proteomics       Date:  2014-01-06       Impact factor: 5.911

Review 7.  Eosinophils: a review.

Authors:  B J McEwen
Journal:  Vet Res Commun       Date:  1992       Impact factor: 2.459

8.  IL-16 in the airways of lung allograft recipients with acute rejection or obliterative bronchiolitis.

Authors:  M Laan; A Lindén; G C Riise
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

9.  IL-16 promotes T. whipplei replication by inhibiting phagosome conversion and modulating macrophage activation.

Authors:  Eric Ghigo; Abdoulaye Oury Barry; Lionel Pretat; Khatoun Al Moussawi; Benoît Desnues; Christian Capo; Hardy Kornfeld; Jean-Louis Mege
Journal:  PLoS One       Date:  2010-10-21       Impact factor: 3.240

10.  Interleukin 16 (IL-16). IUIS/WHO Standing Committee on Interleukin Designation.

Authors: 
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.